StockData
AbbVie Inc. logo

AbbVie Inc. (ABBV) operating KPIs

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)

Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%

AbbVie adjusted Diluted Earnings Per Share — Non-GAAP ($/sh) ($)

Form 8-K Non-GAAP Reconciliations

QuarterlyAnnual
Latest, FY2025
10
Period ended Dec 31, 2025
Change on a year earlier
-1.2%
10.12 in FY2024
History
5 years
Since FY2021
Sources
1
Proxy Statement (DEF 14A) (abbv-20260508xdef14a.htm, filed 2026-03-23)

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAdjusted Diluted Earnings Per Share — Non-GAAP ($/sh) ($)Year on yearSource
FY2025Dec 31, 202510-1.2%Proxy Statement (DEF 14A) (abbv-20260508xdef14a.htm, filed 2026-03-23) ↗
FY2024Dec 31, 202410.12-8.9%Proxy Statement (DEF 14A) (abbv-20260508xdef14a.htm, filed 2026-03-23) ↗
FY2023Dec 31, 202311.11-19.3%Proxy Statement (DEF 14A) (abbv-20260508xdef14a.htm, filed 2026-03-23) ↗
FY2022Dec 31, 202213.77+16.4%Proxy Statement (DEF 14A) (abbv-20260508xdef14a.htm, filed 2026-03-23) ↗
FY2021Dec 31, 202111.83–Proxy Statement (DEF 14A) (abbv-20260508xdef14a.htm, filed 2026-03-23) ↗

Breakdown

What makes up adjusted diluted earnings per share — non-gaap ($/sh)

Cite this data

StockData. (2026). AbbVie Adjusted Diluted Earnings Per Share — Non-GAAP ($/sh) ($), annual FY2021–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/nongaap_adj_eps

See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.